Use of Extracellular Monomeric Ubiquitin as a Therapeutic Option for Major Depressive Disorder
Major depressive disorder (MDD) is a mood disorder that has become a global health emergency according to the World Health Organization (WHO). It affects 280 million people worldwide and is a leading cause of disability and financial loss. Patients with MDD present immunoendocrine alterations like c...
Saved in:
Main Authors: | José Luis Maldonado-García (Author), Lissette Haydee García-Mena (Author), Danelia Mendieta-Cabrera (Author), Gilberto Pérez-Sánchez (Author), Enrique Becerril-Villanueva (Author), Samantha Alvarez-Herrera (Author), Toni Homberg (Author), Luis Vallejo-Castillo (Author), Sonia Mayra Pérez-Tapia (Author), Martha C. Moreno-Lafont (Author), Daniel Ortuño-Sahagún (Author), Lenin Pavón (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Almost 50 Years of Monomeric Extracellular Ubiquitin (eUb)
by: Ivette Mendoza-Salazar, et al.
Published: (2024) -
Imipramine Administration in <i>Brucella abortus 2308</i>-Infected Mice Restores Hippocampal Serotonin Levels, Muscle Strength, and Mood, and Decreases Spleen CFU Count
by: José Luis Maldonado-García, et al.
Published: (2023) -
Concomitant Treatment with Doxycycline and Rifampicin in Balb/c Mice Infected with <i>Brucella abortus</i> 2308 Fails to Reduce Inflammation and Motor Disability
by: José Luis Maldonado-García, et al.
Published: (2024) -
Inmunorreactividad antineural sérica en pacientes con fibromialgia. Estudio preliminar
by: Dora L. de la Cruz-Aguilera, et al.
Published: (2022) -
Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia
by: Samantha Alvarez-Herrera, et al.
Published: (2024)